Hans Morreau
- Pathology and Forensic Medicine top 0.1%
- Genetic factors in colorectal cancer 119
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 66
- Oncology top 0.5%
- Colorectal Cancer Screening and Detection 38
- Colorectal Cancer Treatments and Studies 32
- Pancreatic and Hepatic Oncology Research 19
- Nephrology top 1%
-
- Thyroid Cancer Diagnosis and Treatment 28
-
- Colorectal and Anal Carcinomas 15
-
- BRCA gene mutations in cancer 11
- Co-authors
- Tom van WezelHans F. A. VasenFrederik J. HesRob A.�E.�M. TollenaarJuul WijnenMarjo van PuijenbroekRonald van EijkJohannes W. A. Smit
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Hans Morreau
201 papers receiving 8.2k citations
Peers
Comparison fields: 5 of 134
- Pathology and Forensic Medicine 3.4k
- Cancer Research 2.4k
- Oncology 4.0k
- Nephrology 449
- Endocrinology, Diabetes and Metabolism 949
Countries citing papers authored by Hans Morreau
This map shows the geographic impact of Hans Morreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Morreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Morreau more than expected).
Fields of papers citing papers by Hans Morreau
This network shows the impact of papers produced by Hans Morreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Morreau. The network helps show where Hans Morreau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans Morreau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 10 | |
| 6 | 2022 | 47 | |
| 7 | 2021 | 29 | |
| 8 | 2018 | 27 | |
| 9 | 2017 | 9 | |
| 10 | Predictive Biomarkers for Short-Term Survival After Curative Intent Pancreatic Cancer Surgery : Identifying the Biologically Ill-Fated | 2016 | 3 |
| 11 | Transforming Growth Factor beta Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2 | 2015 | 1 |
| 12 | 2012 | 28 | |
| 13 | 2011 | 128 | |
| 14 | 2009 | 53 | |
| 15 | 2008 | 35 | |
| 16 | 2008 | 30 | |
| 17 | The Bone Morphogenetic Protein Pathway Is Inactivated in the Majority of Sporadic Colorectal Cancers | 2008 | 1 |
| 18 | Prognosis prediction of stage II colon cancer by gene expression profiling | 2007 | 2 |
| 19 | 2006 | 45 | |
| 20 | 2005 | 51 |
About Hans Morreau
Hans Morreau is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 207 papers that have together received 8.3k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (119 papers), Cancer Genomics and Diagnostics (66 papers), Colorectal Cancer Screening and Detection (38 papers), Colorectal Cancer Treatments and Studies (32 papers), Thyroid Cancer Diagnosis and Treatment (28 papers), Pancreatic and Hepatic Oncology Research (19 papers), Colorectal and Anal Carcinomas (15 papers) and BRCA gene mutations in cancer (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.4k citations), Cancer Research (2.4k citations), Oncology (4.0k citations), Nephrology (449 citations) and Endocrinology, Diabetes and Metabolism (949 citations). Hans Morreau has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Tom van Wezel, Hans F. A. Vasen, Frederik J. Hes, Rob A.�E.�M. Tollenaar, Juul Wijnen, Marjo van Puijenbroek, Ronald van Eijk, Johannes W. A. Smit, Maartje Nielsen and Carli M.J. Tops. Their work appears in journals such as Gastroenterology, BMC Cancer, Familial Cancer, Clinical Cancer Research and European Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.